SEC Form 4 research
| Issuer | Kailera Therapeutics, Inc. |
|---|---|
| Tickers | KLRA |
| Reporting owners | 32 |
| Officers and directors | 2 |
| Last public filing | 2026-09-09 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-09 | 2026-09-07 | Nicholson Nur | A | 220,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.